A comprehensive document on platform trials is now available

The domain of EU-PEARL’s research, Integrated Research Platforms (IRPs) and platform trials is relatively new and consequently the vocabulary is still work in progress.  Hence, the need to develop a common understanding and usage of terminology beyond EU-PEARL. With this goal in mind, D2.1. Report on Terminology, References and Scenarios for Platform Trials and Master Protocols has been put together by work package 2.

This new resource intends to break down any potential barriers to communicate with the wider world and to promote the use of a standard terminology across the sphere of platform trials research.

The document includes key terms that range from comprehensive definitions of master protocol elements and its different types, to statistical terminology or biomarkers terms.

Besides, the deliverable delves into the platform trials approach and offers a wide range of materials (beyond terminology) to better understand its relevance and scope. It incorporates:

  • a curated and rated set of publications references for platform trials,
  • a summary of the trials using this innovative methodology
  • a description of features used in this type of studies and finally,
  • operational platform trials experiences that can inform the new paradigm of IRPs that EU-PEARL is building.

All in all, to advance together towards a new paradigm in clinical research, words are also of essence.

Read or download the deliverable here.

Signup to stay informed